E. Jenny Heathcote - Concepedia

Author

E. Jenny Heathcote

Also Known As

E HEATHCOTE, E Heathcote, E J Heathcote, E Jenny Heathcote, E Jenny L. Heathcote, E. Heathcote, E. J. HEATHCOTE, E. J. Heathcote, E. J. L. Heathcote, E. Jenny Heathcote

103

Publications

11.9K

Citations

H-Index

Concepts

All Affiliations

University of Toronto University Health Network Toronto Western Hospital Hôpital Beaujon University of Calgary

About

E. Jenny Heathcote is an author at University of Toronto specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	3.2K
2	Health Sciences	2	2	77
3	Social Sciences	1	1	45
4	Epidemiology	1	1	45
5	Gastroenterology	1	1	642

E. Jenny Heathcote

Publications

10.2K

Citations

H-Index

Page 1

	Year	Citations
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B Patrick Marcellin, E. Jenny Heathcote, Ed Gane, New England Journal of Medicine	2008	1.2K
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote, New England Journal of Medicine	2003	996
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis E. Jenny Heathcote, Mitchell L. Shiffman, W. Graham E. Cooksley, New England Journal of Medicine	2000	885
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote, Gastroenterology HepatologyViral HepatitisPharmacologyHepatitis BHepatitis	2006	882
Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B Ching‐Lung Lai, Edward Gane, Yun‐Fan Liaw, New England Journal of Medicine	2007	773
Long-term safety of lamivudine treatment in patients with chronic hepatitis B Anna S. Lok, Ching‐Lung Lai, Nancy Leung, Gastroenterology HepatologyViral HepatitisMedicineHepatitis BHepatitis	2003	766
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis R.E. Poupon, K. Lindor, Karen Cauch‐Dudek, Gastroenterology HepatologyBiliary TractLiver PhysiologyControlled TrialsPharmacology	1997	642
Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis Bart J. Veldt, E. Jenny Heathcote, Heiner Wedemeyer, Annals of Internal Medicine	2007	600
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ). Marion G. Peters, Hie‐Won Hann, Paul Martin, Gastroenterology	2003	553
Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote, New England Journal of Medicine	2005	535

Page 1